SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.03.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis buy | Kepler Cheuvreux | |
| 23.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.03.17 | Roche buy | Société Générale Group S.A. (SG) | |
| 23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.03.17 | Roche buy | Deutsche Bank AG | |
| 23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.03.17 | Novartis Hold | Deutsche Bank AG | |
| 15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | Novartis Neutral | UBS AG | |
| 10.03.17 | Novartis Hold | Deutsche Bank AG | |
| 09.03.17 | Novartis buy | Jefferies & Company Inc. | |
| 09.03.17 | Roche buy | Jefferies & Company Inc. | |
| 08.03.17 | Novartis Underweight | Barclays Capital | |
| 08.03.17 | Roche overweight | Barclays Capital | |
| 08.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 07.03.17 | Novartis Underperform | BNP PARIBAS | |
| 03.03.17 | Roche overweight | JP Morgan Chase & Co. | |
| 03.03.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.02.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 24.02.17 | Roche buy | Deutsche Bank AG | |
| 20.02.17 | Roche buy | UBS AG | |
| 17.02.17 | Roche buy | Jefferies & Company Inc. | |
| 17.02.17 | Novartis buy | Jefferies & Company Inc. | |
| 17.02.17 | Roche Hold | Kepler Cheuvreux | |
| 15.02.17 | Roche overweight | JP Morgan Chase & Co. | |
| 15.02.17 | Roche buy | Citigroup Corp. | |
| 06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 02.02.17 | Roche overweight | Morgan Stanley | |
| 02.02.17 | Roche overweight | JP Morgan Chase & Co. | |
| 02.02.17 | Roche buy | Deutsche Bank AG | |
| 02.02.17 | Roche Hold | HSBC | |
| 01.02.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.17 | Roche Hold | Baader Bank | |
| 31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.01.17 | Novartis Neutral | UBS AG | |
| 30.01.17 | Novartis buy | HSBC |